Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.Malcolm A. Smith, Richard S. Ungerleider, D Arthur et al.|Journal of Clinical Oncology|1996Cited by 914
Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)Kirk R. Schultz, Bruce M. Camitta, Elizabeth A. Raetz et al.|Blood|2006Cited by 475
Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapseVirginia Pérez-Andreu, Jun J. Yang, Kathryn G. Roberts et al.|Nature Genetics|2013Cited by 308
Reinduction Platform for Children With First Marrow Relapse of Acute Lymphoblastic Leukemia: A Children's Oncology Group StudyElizabeth A. Raetz, William L. Carroll, Michael J. Borowitz et al.|Journal of Clinical Oncology|2008Cited by 219
Efficacy and safety of rasburicase, a recombinant urate oxidase (Elitek™), in the management of malignancy-associated hyperuricemia in pediatric and adult patients: final results of a multicenter compassionate use trialSima Jeha, C‐H Pui, H. Kantarjian et al.|Leukemia|2004Cited by 180